Back

Clinical impact of acquired risk factors in TTN-mediated dilated cardiomyopathy

30 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Ventricular Arrhythmias and SCD: Risk Factors and Risk Assessment Idiopathic Dilated Cardiomyopathy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor John Giudicessi

Mayo Clinic, Rochester (United States of America)

6 More presentations in this session

Presentation thumbnail
Mutation site-specific risk profile in patients with Type 1 Long QT Syndrome
Mr A. Trancuccio (Pavia, IT)
Abstract Slides
Presentation thumbnail
Novel risk factor for fatal arrhythmia in Brugada syndrome
Doctor R. Nishinarita (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Novel insights on Andersen-Tawil syndrome type 1
Doctor A. Mazzanti (Pavia, IT)
Abstract Slides
Presentation thumbnail
MOG1 restores the expression and function of SCN5A-p.R104W through sec23a-mediated forward trafficking
Doctor L. Luo (Xi'an, CN)
Abstract Slides
Presentation thumbnail
Silent myocardial infarction among young sudden cardiac death victims
Mr J. Vahatalo (Kemi, FI)
Abstract Slides

Access the full session

Session thumbnail
Ventricular Arrhythmias and SCD: Risk Factors and Risk Assessment

The Event

Event poster

ESC Congress 2020

30 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Session
Risk assessment and prevention of sudden cardiac death in cardiomyopathies
thumbnail
Congress Session
Gaps in risk stratification for patients with structural heart disease
thumbnail
Congress Presentation
A patient with dilated cardiomyopathy, mildly reduced ejection fraction and left ventricular scarring: what do the guidelines say?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources